Search Results - "Qian, Jane"

A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials by Pénzváltó, Zsófia, Chen, Jane Qian, Tepper, Clifford G., Davis, Ryan R., Silvestrini, Matthew T., Umeh-Garcia, Maxine, Sweeney, Colleen, Borowsky, Alexander D.

“…In order to develop a practical model of breast cancer, with in vitro and syngeneic, immune-intact, in vivo growth capacity, we established a primary cell line…”
Get full text

Foreign firms’ strategic positioning and performance in a host market: A resource partitioning perspective by Xie, Henry Yu, Xie, Qian (Jane), Zhao, Hongxin

“…PurposeStrategic positioning of foreign firms in a host market is vital for their success. By integrating the resource partitioning theory and the…”
Get full text

Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non–Small-Cell Lung Cancer by RUDIN, Charles M, MAUER, Ann, JANE QIAN, PRADHAN, Rajendra, DOWELL, Barry, KRIVOSHIK, Andrew, GORDON, Gary, SMAKAL, Martin, JUERGENS, Rosalyn, SPELDA, Stanislav, WERTHEIM, Michael, COATES, Andrew, MCKEEGAN, Evelyn, ANSELL, Peter, XIANGDONG ZHOU

“…ABT-751 is an antimitotic and vascular disrupting agent with potent preclinical anticancer activity. We conducted a phase I and randomized double-blind phase…”
Get full text

Establishment of clonal MIN-O transplant lines for molecular imaging via lentiviral transduction & in vitro culture by Boucher, David L, Chen, Jane Qian, Cherry, Simon R, Borowsky, Alexander D

“…As the field of molecular imaging evolves and increasingly is asked to fill the discovery and validation space between basic science and clinical applications,…”
Get full text

On the determinants of post-entry strategic positioning of foreign firms in a host market: A “strategy tripod” perspective by Xie, Yu Henry, Zhao, Hongxin John, Xie, Qian Jane, Arnold, Mark

“…The post-entry strategic positioning in a host market is important for MNEs’ success, as firms must position properly in the marketplace to gain competitive…”
Get full text

Mammary carcinoma behavior is programmed in the precancer stem cell by Damonte, Patrizia, Hodgson, J Graeme, Chen, Jane Qian, Young, Lawrence J T, Cardiff, Robert D, Borowsky, Alexander D

“…The 'MINO' (mammary intraepithelial neoplasia outgrowth) mouse model of ductal carcinoma in situ (DCIS) consists of six lines with distinct morphologic…”
Get full text

Pseudotranslation, intertextuality and metafictionality: three case studies of pseudotranslation from early twentieth-century China by Liu, Jane Qian

“…The turn of the twentieth century saw a growing number of works of pseudotranslation in China. Pseudotranslation engages with authentic translation on three…”
Get full text

The Making of Transcultural Lyricism in Su Manshu's Fiction by Liu, Jane Qian

Get full text

Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study by Chabot, Pierre, Hsia, Te-Chun, Ryu, Jeong-Seon, Gorbunova, Vera, Belda-Iniesta, Cristobal, Ball, David, Kio, Ebenezer, Mehta, Minesh, Papp, Katherine, Qin, Qin, Qian, Jane, Holen, Kyle D., Giranda, Vince, Suh, John H.

“…Veliparib is a potent, orally bioavailable, poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor that crosses the blood–brain barrier and has been…”
Get full text

Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study by Mehta, Minesh P., Wang, Ding, Wang, Fen, Kleinberg, Lawrence, Brade, Anthony, Robins, H. Ian, Turaka, Aruna, Leahy, Terri, Medina, Diane, Xiong, Hao, Mostafa, Nael M., Dunbar, Martin, Zhu, Ming, Qian, Jane, Holen, Kyle, Giranda, Vincent, Curran, Walter J.

“…Veliparib, a potent, oral PARP inhibitor, potentiates the antitumor activity of radiation therapy and crosses the blood–brain barrier. This was a phase 1…”
Get full text

A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC) by Mizugaki, Hidenori, Yamamoto, Noboru, Nokihara, Hiroshi, Fujiwara, Yutaka, Horinouchi, Hidehito, Kanda, Shintaro, Kitazono, Satoru, Yagishita, Shigehiro, Xiong, Hao, Qian, Jane, Hashiba, Hideyuki, Shepherd, Stacie P., Giranda, Vincent, Tamura, Tomohide

“…Abstact Introduction Veliparib is a potent, orally bioavailable PARP inhibitor that enhances efficacy of DNA-damaging chemotherapeutic agents. The study…”
Get full text

Foreign firms’ strategic positioning and performance in a host market by Xie, Henry Yu, Xie, Qian (Jane), Zhao, Hongxin

“…Purpose Strategic positioning of foreign firms in a host market is vital for their success. By integrating the resource partitioning theory and the…”
Get full text

Quality of life by smoking status in patients with metastatic or advanced NSCLC from Phase 2 clinical trial of veliparib with carboplatin and paclitaxel by Bonnet, Patrick, Cloutier, Martin, McKee, Mark D., Gauthier-Loiselle, Marjolaine, Qian, Jane, Mu, Fan, Qin, Qin Q., Guerin, Annie, Wu, Eric Qiong, Giranda, Vincent L.

“…Abstract only…”
Get full text

A phase 3 randomized trial of veliparib (ABT-888) plus carboplatin and paclitaxel versus investigator’s choice of standard chemotherapy in previously untreated patients with metastatic/advanced non-squamous (NSq) non-small cell lung cancer (NSCLC) by McKee, Mark D., Pedersen, Michelle, DeLuca, Angela, Qin, Qin, Qian, Jane, Irving, Jade, Ansell, Peter, Leahy, Terri, Caskey, Courtney, Giranda, Vincent L.

“…Abstract only…”
Get full text

Phase III randomized, placebo-controlled trial of carboplatin (C) and paclitaxel (P) with/without veliparib (ABT-888) in HER2- BRCA -associated locally advanced or metastatic breast cancer (BC) by Huggins-Puhalla, Shannon Leigh, Han, Hyo S., Diéras, Véronique, Friedlander, Michael, Somlo, George, Arun, Banu, Wildiers, Hans, Kaufman, Bella, Ayoub, Jean-Pierre M., Shah, Melissa, Burmedi, David, Qin, Qin, Qian, Jane, Giranda, Vincent L., Shepherd, Stacie Peacock

“…Abstract only 155 Background: BRCA-mutated tumors are more susceptible to platinum therapy and PARP inhibitors due to underlying defects in homologous…”
Get full text

Results of a randomized, global, multi-center study of whole-brain radiation therapy (WBRT) plus veliparib or placebo in patients (pts) with brain metastases (BM) from non-small cell lung cancer (NSCLC) by Chabot, Pierre, Ryu, Jeong-Seon, Gorbunova, Vera, Belda, Cristobal, Ball, David, Kio, Ebenezer A., Mehta, Minesh, Papp, Katherine, Qin, Qin, Qian, Jane, Holen, Kyle D., Giranda, Vincent L., Suh, John H.

“…Abstract only…”
Get full text

Phase 3 randomized, placebo-controlled trial of carboplatin (C) and paclitaxel (P) with/without veliparib (ABT-888) in HER2- BRCA -associated locally advanced or metastatic breast cancer (BC) by Puhalla, Shannon, Han, Hyo S., Diéras, Véronique, Friedlander, Michael, Somlo, George, Arun, Banu, Wildiers, Hans, Kaufman, Bella, Ayoub, Jean-Pierre M., Shan, Melissa, Burmedi, David, Qin, Qin, Qian, Jane, Giranda, Vincent L., Shepherd, Stacie Peacock

“…Abstract only…”
Get full text

Smoking status to predict sensitivity to PARP inhibitor, veliparib, in patients with advanced NSCLC by Ramalingam, Suresh S., Blais, Normand, Mazières, Julien, Reck, Martin, Jones, C. Michael, Juhasz, Erzsebet, Urban, Laszlo, Orlov, Sergey, Barlesi, Fabrice, Kio, Ebenezer A., Keilholz, Ulrich, Qian, Jane, Qin, Qin, Dunbar, Martin, Xiong, Hao, Mittapalli, Rajendar K., Ansell, Peter, McKee, Mark D., Giranda, Vincent L., Gorbunova, Vera

“…Abstract only…”
Get full text

A Comparative Study of Modeling the Magnetostatic Field in a Current-Carrying Plate Containing an Elliptic Hole by Xiaoqing Jin, Hasebe, N., Keer, L.M., Wang, Q.J.

“…The presence of crack-like defects can cause an uneven distribution of the electric current density in a cracked conductor. To investigate the perturbation of…”
Get full text

A Thermoelastic Asperity Contact Model Considering Steady-State Heat Transfer by Wang, Qian (Jane), Liu, Geng

“…One of the important issues in mixed lubrication is the contact problem involving frictional heating in the interface of contacting bodies. Due to contact and…”
Get full text